Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Heidegger

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Science Immunology|September 15, 2019
RIG-I activation is critical for responsiveness to checkpoint blockadeSimon Heidegger, Alexander Wintges, Florian Stritzke, et al.
Cell Reports. Medicine|September 1, 2023
Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapySimon Heidegger, Florian Stritzke, Sarah Dahl, et al.
Science Translational Medicine|April 21, 2017
RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injuryJulius C Fischer, Michael Bscheider, Gabriel Eisenkolb, et al.
Nature Cancer|January 3, 2024
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantationErik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, et al.
Nature Communications|October 20, 2025
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regenerationSascha Göttert, Erik Thiele Orberg, Kaiji Fan, et al.
Signal Transduction and Targeted Therapy|November 25, 2025
Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injuryJulius C Fischer, Sascha Göttert, Maximilian Giller, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Science Immunology|September 15, 2019
RIG-I activation is critical for responsiveness to checkpoint blockadeSimon Heidegger, Alexander Wintges, Florian Stritzke, et al.
Cell Reports. Medicine|September 1, 2023
Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapySimon Heidegger, Florian Stritzke, Sarah Dahl, et al.
Science Translational Medicine|April 21, 2017
RIG-I/MAVS and STING signaling promote gut integrity during irradiation- and immune-mediated tissue injuryJulius C Fischer, Michael Bscheider, Gabriel Eisenkolb, et al.
Nature Cancer|January 3, 2024
Bacteria and bacteriophage consortia are associated with protective intestinal metabolites in patients receiving stem cell transplantationErik Thiele Orberg, Elisabeth Meedt, Andreas Hiergeist, et al.
Nature Communications|October 20, 2025
The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regenerationSascha Göttert, Erik Thiele Orberg, Kaiji Fan, et al.
Signal Transduction and Targeted Therapy|November 25, 2025
Tissue-adapted Tregs harness inflammatory signals to promote intestinal repair from therapy-related injuryJulius C Fischer, Sascha Göttert, Maximilian Giller, et al.
Pageof 4